drugset / Trial / NCT02862704
A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to collect the data on the safety and potential effectiveness of intra-tumor injection of MG7-CART cells under ultrasound guidance in patients with liver metastases expressing MG7 positively.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-05
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MG7-CART | Cell therapy | — | Other |
Indications
No indication recorded.